CLDI.WS
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
CLDI.WS
Delisted
CLDI.WS was delisted on the 17th of October, 2024.
15 hedge funds and large institutions have $99.4K invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
2
Closed
–
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$3K
Top Buyers
| 1 |
DCM
1
Driehaus Capital Management
Chicago,
Illinois
|
$9.3K |
| 2 |
CS
2
Clear Street
New York
|
$87 |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$70 |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$926 |
Top Sellers
| 1 |
HCM
1
Highbridge Capital Management
New York
|
$20.7K |
| 2 |
SCM
2
Shaolin Capital Management
Miami,
Florida
|
$4.33K |
| 3 |
SOA
3
Sea Otter Advisors
Miami,
Florida
|
$0 |
